,IEDB_ID,protein,alignment,matched,sequence,offset,host,assay_type,assay_result,mhc_allele,mhc_class,exp_method,measurement_type
0,307,D064370,20200505,ATO98145.1,AALVSGTATAGWTFGAG,835,Human,B Cell,Positive,,,ELISA,qualitative binding
1,462,D064370,20200505,QIS60846.1,AATKMSECVLGQSKRVD,1024,Human,B Cell,Positive,,,ELISA,qualitative binding
2,525,D064370,20200505,ABE77216.1,AAYFVGYLKPTTFMLKY,249,Human,B Cell,Positive,,,ELISA,qualitative binding
3,971,D064370,20200505,ABE77216.1,AEHVDT----SYECDIPIGA,638,Chicken,B Cell,Positive-Low,,,ELISA,qualitative binding
4,1460,D064370,20200505,ABE77216.1,AGCLIGAEHVDT----SYECD,632,Human,B Cell,Positive,,,ELISA,qualitative binding
5,2053,D064370,20200505,ABE77216.1,AIPTNFSISITTEVMPV,694,Human,B Cell,Positive,,,ELISA,qualitative binding
6,2092,D064370,20200505,QIS60846.1,AISSVLNDILSRLDKVE,971,Human,B Cell,Positive,,,ELISA,qualitative binding
7,2769,D064370,20200505,ABE77216.1,ALNCYW,470,Human,B Cell,Positive,,,biological activity,antibody binding
8,2770,D064370,20200505,ABE77216.1,ALNCYW---------------------------PLNDY--------------------------GFY-----------------------------------T-----TTGIGYQPYRVVVLSFEL,470,Human,B Cell,Positive,,,ELISA,qualitative binding
9,3176,D064370,20200505,QIS60846.1,AMQMAYRF,898,Human,B Cell,Positive,,,biological activity,antibody binding
10,3983,D064370,20200505,AIA62277.1,AQKFNGLTVLPPLLTDD,814,Human,B Cell,Positive,,,ELISA,qualitative binding
11,4129,D064370,20200505,QIQ54048.1,ARDLICAQKFNGLTVLP,841,Human,B Cell,Negative,,,ELISA,qualitative binding
12,68,D064370,20200505,ABE77216.1,AAAYFVGYLK,248,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
13,69,D064370,20200505,ABE77216.1,AAAYFVGYLKPTTFM,248,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
14,306,D064370,20200505,ATO98145.1,AALVSGTATAGWTFG,835,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
15,524,D064370,20200505,ABE77216.1,AAYFVGYLK,249,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
16,803,D064370,20200505,QIQ54048.1,ADYSVLYNS-T,362,Human,MHC Binding,Negative,HLA-B*18:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
17,999,D064370,20200505,QIS60846.1,AEIRASANLA,1015,Chimpanzee,MHC Binding,Positive-Low,Patr-B*24:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
18,1220,D064370,20200505,QIS60846.1,AEVQIDRLI,988,Chimpanzee,MHC Binding,Negative,Patr-B*24:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
19,1221,D064370,20200505,QIS60846.1,AEVQIDRLIT,988,Human,MHC Binding,Negative,HLA-B*18:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
20,1358,D064370,20200505,ABE77216.1,AFNCTFEYI,155,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
21,1398,D064370,20200505,AAU93320.1,AFSLDVSE-K,166,Human,MHC Binding,Negative,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
22,1597,D064370,20200505,AVP78042.1,AGLIAIVMVTILLCC,1193,Human,MHC Binding,Positive-Low,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
23,2121,D064370,20200505,AVP78042.1,AIVMVTILLCCMTSC,1197,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
24,2801,D064370,20200505,QIQ54048.1,ALNTLVKQL,953,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
25,2986,D064370,20200505,ALJ94036.1,ALVSGTATA,864,Human,MHC Binding,Negative,HLA-A*68:02,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
26,3392,D064370,20200505,ATO98145.1,ANQFNKAISQIQESL,884,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
27,3478,D064370,20200505,QIQ54048.1,APAICHE---GKA,1073,Human,MHC Binding,Negative,HLA-B*35:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
28,3492,D064370,20200505,ABE77216.1,APATVCGPK-L,505,Human,MHC Binding,Negative,HLA-B*35:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
29,3589,D064370,20200505,QIQ54048.1,APHGVVFLHV,1051,Human,MHC Binding,Negative,HLA-B*51:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
30,3939,D064370,20200505,QIS60846.1,AQALNTLVK,955,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
31,3982,D064370,20200505,QIQ54048.1,AQKFNGLTVLPPLLT,847,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
32,4321,D064370,20200505,QIS60846.1,ASANLAATK,1019,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
33,4941,D064370,20200505,ABE77216.1,ATEKSNV-------------------VRGWV,90,Human,B Cell,Positive,,,ELISA,qualitative binding
34,5773,D064370,20200505,AKZ19076.1,AYFPREGVFVFNGT----------SWF,1054,Human,B Cell,Positive,,,ELISA,qualitative binding
35,5927,D064370,20200505,ABE77216.1,AYSNNTIAIPTNFSISI,687,Human,B Cell,Positive,,,ELISA,qualitative binding
36,6011,D064370,20200505,ATO98157.1,CANLLLQYGSFCTQLNRALSGIA,730,Human,B Cell,Positive,,,ELISA,qualitative binding
37,6040,D064370,20200505,ABE77216.1,CASYHTVSL----L-RSTS-----QKS,656,Human,B Cell,Positive,,,ELISA,qualitative binding
38,6110,D064370,20200505,ABE77216.1,CDIPIGAGICASYHTVS,647,Human,B Cell,Positive,,,ELISA,qualitative binding
39,6332,D064370,20200505,ABE77216.1,CGPK-L-----STDLIKNQCVNF,510,Human,B Cell,Positive,,,ELISA,qualitative binding
40,6333,D064370,20200505,ABE77216.1,CGPK-L-----STDLIKNQCVNFNFNGLTGTGVLTP-SSKRFQPFQQFG,510,Human,B Cell,Positive,,,ELISA,qualitative binding
41,6334,D064370,20200505,ABE77216.1,CGPK-L-----STDLIKNQCVNFNFNGLTGTGVLTP-SSKRFQPFQQFGRDVSDFTD,510,Human,B Cell,Positive,,,western blot,qualitative binding
42,6476,D064370,20200505,QIS60846.1,CK-FDEDDSEPVLKGVKLHYT,1253,Rabbit,B Cell,Positive-Low,,,immunohistochemistry,qualitative binding
43,6562,D064370,20200505,ATO98193.1,CLG---DINARDLICAQKFN,807,Human,B Cell,Negative,,,ELISA,qualitative binding
44,7064,D064370,20200505,ABE77216.1,CSQNPLAELKCSVKSFE,277,Human,B Cell,Positive,,,ELISA,qualitative binding
45,7065,D064370,20200505,ABE77216.1,CSQNPLAELKCSVKSFEI,277,Mouse,B Cell,Positive,,,biological activity,neutralization
46,7066,D064370,20200505,ABE77216.1,CSQNPLAELKCSVKSFEIDKGIYQTSNFRVVPSGD,277,Human,B Cell,Positive,,,ELISA,qualitative binding
47,7128,D064370,20200505,ABE77216.1,CTDVSTAIHADQLTPAW,602,Human,B Cell,Positive,,,ELISA,qualitative binding
48,7129,D064370,20200505,ABE77216.1,CTDVSTAIHADQLTPAWRIYST-----GNNVFQTQAG,602,Human,B Cell,Positive,,,ELISA,qualitative binding
49,7193,D064370,20200505,ABE77216.1,CT-PPALNCYW---------------------------PLNDY--------------------------GF,466,Human,B Cell,Positive,,,ELISA,qualitative binding
50,7216,D064370,20200505,ABE77216.1,CTTFD---------DVQA-------PNYTQHTSSMR,18,Rabbit,B Cell,Positive-Intermediate,,,immunohistochemistry,qualitative binding
51,7217,D064370,20200505,ABE77216.1,CTTFD---------DVQA-------PNYTQHTSSMRGVYYPDEIFR,18,Human,B Cell,Positive,,,ELISA,qualitative binding
52,7277,D064370,20200505,ACO72893.1,CVKSQTTRIN,1081,Mouse,B Cell,Positive,,,ELISA,qualitative binding
53,7280,D064370,20200505,ABE77216.1,CVLAWNTRNIDATS---------------------------TGN,418,Human,B Cell,Positive,,,ELISA,qualitative binding
54,7383,D064370,20200505,ABE77216.1,CYGVSATKLNDLCFSNV,365,Human,B Cell,Positive,,,ELISA,qualitative binding
55,7452,D064370,20200505,ABE77216.1,CYW---------------------------PLNDY--------------------------GFY-----------------------------------T-----TTGIG,473,Human,B Cell,Positive,,,ELISA,qualitative binding
56,7868,D064370,20200505,QIS60846.1,DDSEPVLKGVKLHYT,1258,Human,B Cell,Positive,,,ELISA,qualitative binding
57,8239,D064370,20200505,YP_003858584.1,DFCGKGYHLMSFPQAAP,1026,Human,B Cell,Positive,,,ELISA,qualitative binding
58,8413,D064370,20200505,ABE77216.1,DGIYFAATEKSNV-------------------VRGW,84,Human,B Cell,Positive,,,ELISA,qualitative binding
59,9007,D064370,20200505,QIQ54048.1,DKYFKNHTSPDVDLGD,1148,Rabbit,B Cell,Positive-Low,,,immunohistochemistry,qualitative binding
60,9094,D064370,20200505,QIS60846.1,DLGD-----ISGINASVVNIQK,1164,Human,B Cell,Positive,,,ELISA,qualitative binding
61,9242,D064370,20200505,ABE77216.1,DLPSGFNTLKPIFKLPL,207,Human,B Cell,Positive,,,ELISA,qualitative binding
62,9365,D064370,20200505,QDF43815.1,DMIAAYTAALVSGTATA,835,Human,B Cell,Positive,,,ELISA,qualitative binding
63,9662,D064370,20200505,ABE77216.1,DPKTSEILDISPCSFGGV,563,Mouse,B Cell,Positive,,,biological activity,neutralization
64,9956,D064370,20200505,ABE77216.1,DRCTTFD---------DVQA-------PNYTQH,16,Human,B Cell,Positive,,,ELISA,qualitative binding
65,10113,D064370,20200505,QIQ54048.1,DSFKEELDKYFKNHTSPDVDLGD-----ISGINASVV,1141,Guinea pig,B Cell,Negative,,,biological activity,neutralization
66,10721,D064370,20200505,ABE77216.1,DVSE-KSGNF--KHLREFVF,170,Human,B Cell,Positive,,,ELISA,qualitative binding
67,4768,D064370,20200505,ABE77216.1,ASSEVAVLY,589,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
68,4877,D064370,20200505,AVP78042.1,ATAGWTFGA,853,Human,MHC Binding,Positive-High,HLA-A*02:03,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
69,5155,D064370,20200505,ABE77216.1,ATS---------------------------TGNYNY,429,Human,MHC Binding,Negative,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
70,5156,D064370,20200505,ABE77216.1,ATS---------------------------TGNYNYK,429,Chimpanzee,MHC Binding,Positive-Low,Patr-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
71,5772,D064370,20200505,ATO98145.1,AYFPREGVF,1047,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
72,5777,D064370,20200505,ABE77216.1,AYFVGYLKPTTFMLK,250,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
73,5908,D064370,20200505,QIS60846.1,AYRFNGIGVTQNVLY,902,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
74,5926,D064370,20200505,ABE77216.1,AYSNNTIAI,687,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
75,6668,D064370,20200505,QIS60846.1,CMTSCCSCLK,1235,Human,MHC Binding,Positive-High,HLA-A*68:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
76,7032,D064370,20200505,Q02385.1,CSLWNGPHL,509,Mouse,MHC Binding,Positive,H2-Db,I,cellular MHC,qualitative binding
77,7192,D064370,20200505,ABE77216.1,CT-PPALNCY,466,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
78,7247,D064370,20200505,QIS60846.1,CVADYSVLY,360,Chimpanzee,MHC Binding,Negative,Patr-B*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
79,7289,D064370,20200505,QIS60846.1,CVNFNFNGLTGTGVL,537,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
80,7382,D064370,20200505,ABE77216.1,CYGVSATKL,365,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
81,7451,D064370,20200505,ABE77216.1,CYW---------------------------PLNDY--------------------------GF,473,Chimpanzee,MHC Binding,Positive-Intermediate,Patr-A*07:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
82,7829,D064370,20200505,QDF43815.1,DDMIAAYTAALVSGT,834,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
83,7928,D064370,20200505,QIS60846.1,DEDDSEPVL,1256,Human,MHC Binding,Negative,HLA-B*18:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
84,9006,D064370,20200505,QIQ54048.1,DKYFKNHTSPDVDLG,1148,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
85,9241,D064370,20200505,ABE77216.1,DLPSGFNTLK,207,Human,MHC Binding,Negative,HLA-A*31:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
86,9421,D064370,20200505,ABE77216.1,DNAFNCTFEY,153,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
87,10112,D064370,20200505,QIS60846.1,DSFKEELDKY,1145,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
88,10418,D064370,20200505,ABE77216.1,DTLYLTQDLFLPFYS,49,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
89,10778,D064370,20200505,QIQ54048.1,DVVNQNAQALNTLVKQL,945,Human,B Cell,Positive,,,ELISA,qualitative binding
90,10779,D064370,20200505,ABE77216.1,DVV----RDLPSGFNTLKPI,203,Rabbit,B Cell,Positive-Intermediate,,,immunohistochemistry,qualitative binding
91,11038,D064370,20200505,QIS60846.1,EAEVQIDRLITGRLQSL,987,Human,B Cell,Positive,,,ELISA,qualitative binding
92,11740,D064370,20200505,QIQ54048.1,EELDKYFKNHTSPDVDL,1145,Human,B Cell,Negative,,,ELISA,qualitative binding
93,12417,D064370,20200505,ABE77216.1,EIDKGIYQTSNFRVVPS,293,Human,B Cell,Positive,,,ELISA,qualitative binding
94,12426,D064370,20200505,QIS60846.1,EIDRLNEVAKNLNESLIDLQELGKYEQY,1181,Human,B Cell,Positive,,,ELISA,qualitative binding
95,14208,D064370,20200505,ATO98145.1,ESLTTTSTALGKLQDVV,896,Human,B Cell,Positive,,,ELISA,qualitative binding
96,14626,D064370,20200505,QIS60846.1,EVAKNLNESLIDLQELG,1187,Human,B Cell,Positive,,,ELISA,qualitative binding
97,15582,D064370,20200505,ABE77216.1,FELCDNPFFAVSKP-M-GT---QTHT,129,Humanized (transgene),B Cell,Positive,,,biological activity,neutralization
98,15783,D064370,20200505,ABE77216.1,FFAVSKP-M-GT---QTHTMIF,136,Human,B Cell,Positive,,,ELISA,qualitative binding
99,15899,D064370,20200505,AGC74176.1,FFSPQIIT-TDNTFVSGNCDVVIGIINNTVYDPLQ--PELDSF,1076,Mouse,B Cell,Positive,,,biological activity,neutralization
100,15903,D064370,20200505,ABE77216.1,FFSTFKCYGVSATKLND,359,Human,B Cell,Positive,,,ELISA,qualitative binding
101,15972,D064370,20200505,QIS60846.1,FGEVF--NAT,337,Human,B Cell,Positive,,,biological activity,antibody binding
102,16183,D064370,20200505,QIQ54048.1,FIEDLLFNKVTLADAGF,812,Human,B Cell,Positive,,,ELISA,qualitative binding
103,16376,D064370,20200505,AAU93320.1,F--KHLREFVFKNKDGFLY,178,Human,B Cell,Positive,,,ELISA,qualitative binding
104,16417,D064370,20200505,AAU93320.1,FKNKDGFLYVYKGYQPI,186,Human,B Cell,Positive,,,ELISA,qualitative binding
105,10965,D064370,20200505,ABE77216.1,DYSVLYNS-TF,350,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
106,11231,D064370,20200505,AAU93320.1,ECANLLLQY,729,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
107,11384,D064370,20200505,QIQ54048.1,EDLLFNKVTLADAGF,814,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
108,12967,D064370,20200505,ABE77216.1,ELCDNPFFA,130,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
109,14045,D064370,20200505,QDF43815.1,ERNFTTAPAICHE---GK,1039,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
110,14630,D064370,20200505,ABE77216.1,EVAVLYQDVNCTDVS,592,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
111,14829,D064370,20200505,ABE77216.1,EVMPVSMAK,706,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
112,15372,D064370,20200505,ABE77216.1,FD---------DVQA-------PNY,21,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
113,15552,D064370,20200505,ABE77216.1,FEIDKGIYQT,292,Human,MHC Binding,Negative,HLA-B*18:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
114,15581,D064370,20200505,ABE77216.1,FELCDNPFF,129,Chimpanzee,MHC Binding,Negative,Patr-B*24:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
115,15584,D064370,20200505,QHR63300.2,FELLNAPAT,514,Human,MHC Binding,Negative,HLA-B*44:02,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
116,15585,D064370,20200505,ABE77216.1,FELLNAPATVCGPK-L,500,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
117,15628,D064370,20200505,ABE77216.1,FERDISNVPF,450,Human,MHC Binding,Negative,HLA-B*45:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
118,15771,D064370,20200505,AAU93320.1,FEYISDAFSL,160,Human,MHC Binding,Negative,HLA-B*45:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
119,16156,D064370,20200505,QIS60846.1,FIAGLIAIV,1219,Human,MHC Binding,Positive-High,HLA-A*02:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
120,16194,D064370,20200505,ABE77216.1,FIFLLFLTL,1,Human,MHC Binding,Negative,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
121,16195,D064370,20200505,ABE77216.1,FIFLLFLTLTSG--------------SDL,1,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
122,16350,D064370,20200505,ABE77216.1,FKCYGVSATKLNDLC,363,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
123,14942,D064370,20200505,ACN89743.1,EWL--TAKSVPSPLNWE,332,Mouse,T Cell,Positive,H2-b class II,II,3H-thymidine,proliferation
124,17132,D064370,20200505,ABE77216.1,F--NATKFPSVYAWERKKI,328,Human,B Cell,Negative,,,ELISA,qualitative binding
125,17524,D064370,20200505,ABE77216.1,FQQFGRDVSDFTDSVRDPKT,547,Chicken,B Cell,Positive-High,,,ELISA,qualitative binding
126,17644,D064370,20200505,ABE77216.1,FRSDTLYLTQDLFLPFY,46,Human,B Cell,Positive,,,ELISA,qualitative binding
127,17929,D064370,20200505,ABE77216.1,FTDSVRDPKTSEILDIS,557,Human,B Cell,Positive,,,ELISA,qualitative binding
128,18161,D064370,20200505,AAU93320.1,FVFNGT----------SWFITQRNFFS,1076,Human,B Cell,Positive,,,ELISA,qualitative binding
129,18515,D064370,20200505,QIS60846.1,GAALQIPFAMQMAYRFN,890,Human,B Cell,Positive,,,ELISA,qualitative binding
130,18594,D064370,20200505,QIS60846.1,GAGICASY,666,Human,B Cell,Positive,,,biological activity,antibody binding
131,19585,D064370,20200505,ATO98193.1,GFMKQYGECLG---DINARD,799,Human,B Cell,Positive,,,ELISA,qualitative binding
132,19657,D064370,20200505,ABE77216.1,GFY-----------------------------------T-----TTGIGYQPYRVVV,481,Human,B Cell,Positive,,,ELISA,qualitative binding
133,20288,D064370,20200505,YP_003858584.1,GIGVTQNVLYENQKQIA,893,Human,B Cell,Positive,,,ELISA,qualitative binding
134,21553,D064370,20200505,ABE77216.1,GNYNYKYRYLRHGKLRPFER,433,Guinea pig,B Cell,Positive,,,ELISA,qualitative binding
135,21675,D064370,20200505,ABE77216.1,GPK-L-----STDLIKNQCVNFNF,511,Mouse,B Cell,Positive,,,biological activity,neutralization
136,22321,D064370,20200505,QIS60846.1,GSFCTQLN,756,Human,B Cell,Positive,,,biological activity,antibody binding
137,17131,D064370,20200505,ABE77216.1,F--NATKFPSVY,328,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
138,17153,D064370,20200505,ABE77216.1,FNGLTGTGVLTP-SSK,528,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
139,17154,D064370,20200505,AIA62277.1,FNGLTVLPPLLTDDM,817,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
140,17341,D064370,20200505,QIS60846.1,F-PNITN-LCPF,328,Chimpanzee,MHC Binding,Positive-High,Patr-B*13:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
141,17356,D064370,20200505,YP_003858584.1,FPQAAPHGVV,1037,Human,MHC Binding,Positive-High,HLA-B*54:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
142,17382,D064370,20200505,AKZ19076.1,FPREGVFVF,1056,Chimpanzee,MHC Binding,Positive-High,Patr-B*13:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
143,17561,D064370,20200505,ABF68959.1,FRAILTAFSP----------AQDIW,230,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
144,17816,D064370,20200505,AIA62277.1,FSQILPDPL-----------KPTKRS,764,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
145,18160,D064370,20200505,AKZ19076.1,FVFNGT----------SWFI,1062,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/competitive/fluorescence,qualitative binding
146,18181,D064370,20200505,ABE77216.1,FVGYLKPTTFMLKYD,252,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
147,18477,D064370,20200505,ABE77216.1,FY-----------------------------------T-----TTGIGY,482,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
148,18514,D064370,20200505,QIS60846.1,GAALQIPFAMQMAYR,890,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
149,18566,D064370,20200505,ABE77216.1,GAEHVDT----SY,637,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
150,19456,D064370,20200505,ABE77216.1,GEVF--NATKF,325,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
151,19593,D064370,20200505,ABE77216.1,GFNTLKPIFK,211,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
152,20379,D064370,20200505,ABE77216.1,GINITNFRAILTAFS,224,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
153,20907,D064370,20200505,QIS60846.1,GLIAIVMVTI,1222,Human,MHC Binding,Positive-High,HLA-A*02:02,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
154,21962,D064370,20200505,QIQ54048.1,GQTGVIADY,412,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,dissociation constant KD (~EC50)
155,22144,D064370,20200505,QIS60846.1,GRLQSLQTY,998,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
156,21552,D064370,20200505,ABE77216.1,GNYNYKYRYLRHGKL,433,Mouse,T Cell,Negative,H2-d class I,I,ICS,IFNg release
157,23051,D064370,20200505,ABE77216.1,GVLTP-SSKRFQPFQQFG,535,Human,B Cell,Positive,,,ELISA,qualitative binding
158,23053,D064370,20200505,ABE77216.1,GVLTP-SSKRFQPFQQFGRDVSDFTDSVRDPK,535,Human,B Cell,Positive,,,ELISA,qualitative binding
159,23296,D064370,20200505,ABE77216.1,GWVFGSTMNNKSQSVII,99,Human,B Cell,Positive,,,ELISA,qualitative binding
160,23437,D064370,20200505,ABE77216.1,GYQPYRVVVLSFELLNA,489,Human,B Cell,Positive,,,ELISA,qualitative binding
161,23438,D064370,20200505,ABE77216.1,GYQPYRVVVLSFELLNAPATV,489,Humanized (transgene),B Cell,Positive,,,biological activity,neutralization
162,23441,D064370,20200505,ARB66065.1,GYRFTNFEP,362,Rabbit,B Cell,Positive,,,ELISA,qualitative binding
163,23520,D064370,20200505,ABE77216.1,HADQLTPAWRIYST-----GNN,610,Human,B Cell,Positive,,,ELISA,qualitative binding
164,23685,D064370,20200505,ATO98145.1,HE---GKAYFPREGV,1043,Human,B Cell,Positive,,,ELISA,qualitative binding
165,24923,D064370,20200505,AAR07631.1,H--TINH--------------------TFGNPVIPFKDG,69,Human,B Cell,Positive,,,ELISA,qualitative binding
166,24978,D064370,20200505,ABE77216.1,HTSSMRGVYYPDEIFRS,32,Human,B Cell,Positive,,,ELISA,qualitative binding
167,25031,D064370,20200505,ABE77216.1,HVDT----SYECDIPIGAGIC,640,Human,B Cell,Positive,,,ELISA,qualitative binding
168,25219,D064370,20200505,ABF68955.1,IAAEQDRNTREVFAQVK,751,Human,B Cell,Positive,,,ELISA,qualitative binding
169,25250,D064370,20200505,ABE77216.1,IADYNYKLPDDFMGCVL,404,Human,B Cell,Positive,,,ELISA,qualitative binding
170,25293,D064370,20200505,AVP78042.1,IAGLIAIVMVTILLCCM,1192,Human,B Cell,Positive,,,ELISA,qualitative binding
171,25378,D064370,20200505,QIQ54048.1,IAPGQTGVIADYNYKLP,409,Human,B Cell,Positive,,,ELISA,qualitative binding
172,26610,D064370,20200505,ABE77216.1,I--IN--------------------NSTNVVIRACN---------FEL,115,Human,B Cell,Positive,,,ELISA,qualitative binding
173,26858,D064370,20200505,ABE77216.1,IKNQCVNFNFNGLTGTGV,519,Mouse,B Cell,Positive,,,biological activity,neutralization
174,27357,D064370,20200505,QIS60846.1,ILSRLDKVEAEVQIDRL,979,Human,B Cell,Positive,,,ELISA,qualitative binding
175,22322,D064370,20200505,QIS60846.1,GSFCTQLNR,756,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
176,22680,D064370,20200505,ABE77216.1,GTGVLTP-SSKRFQPF,533,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
177,22808,D064370,20200505,ABE77216.1,GTSAAAYFV,245,Human,MHC Binding,Positive-High,HLA-A*02:02,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
178,22848,D064370,20200505,ATO98145.1,GT----------SWFITQR,1059,Human,MHC Binding,Positive-High,HLA-A*11:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
179,22975,D064370,20200505,AKZ19076.1,GVFVFNGT----------SWFITQR,1060,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
180,22994,D064370,20200505,QIQ54048.1,GVIADYNYK,415,Human,MHC Binding,Positive-High,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
181,23158,D064370,20200505,ABE77216.1,GVSVITPGTNASSEV,579,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
182,23200,D064370,20200505,QIS60846.1,GVVFLHVTY,1058,Human,MHC Binding,Negative,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
183,23236,D064370,20200505,ABE77216.1,GVYYPDEIFR,38,Human,MHC Binding,Positive-High,HLA-A*68:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
184,23293,D064370,20200505,QIS60846.1,GWTFGAGAALQIPFA,884,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
185,23400,D064370,20200505,ABE77216.1,GYLKPTTFM,254,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
186,23401,D064370,20200505,ABE77216.1,GYLKPTTFML,254,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
187,23436,D064370,20200505,QIS60846.1,GYQPYRVVVL,503,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
188,23519,D064370,20200505,ABE77216.1,HADQLTPAW,610,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
189,24976,D064370,20200505,ABE77216.1,HTSSMRGVY,32,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
190,24977,D064370,20200505,ABE77216.1,HTSSMRGVYY,32,Chimpanzee,MHC Binding,Negative,Patr-B*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
191,25236,D064370,20200505,ALJ94036.1,IAAYTAALVSGTATA,858,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
192,25292,D064370,20200505,AVP78042.1,IAGLIAIVMVTILLC,1192,Human,MHC Binding,Positive-Low,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
193,25540,D064370,20200505,ABE77216.1,IDATS---------------------------TGNY,427,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
194,25662,D064370,20200505,QIS60846.1,IDRLITGRLQSLQTY,992,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
195,25754,D064370,20200505,QIQ54048.1,IEDLLFNKVTLADAG,813,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
196,26198,D064370,20200505,QIS60846.1,IGAGICASY,665,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
197,26710,D064370,20200505,QIS60846.1,IIT-TDNTFV,1113,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
198,27146,D064370,20200505,AVP78042.1,ILLCCMTSC,1203,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
199,27241,D064370,20200505,AIA62277.1,ILPDPL-----------KPT,767,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
200,28512,D064370,20200505,QIS60846.1,ISGINASVVNIQKEIDRLNE,1168,Mouse,B Cell,Positive,,,biological activity,neutralization
201,28513,D064370,20200505,QIS60846.1,ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI,1168,Mouse,B Cell,Positive,,,biological activity,neutralization
202,28548,D064370,20200505,ABE77216.1,ISITTEVMPVSMAKTSV,701,Human,B Cell,Negative,,,ELISA,qualitative binding
203,29108,D064370,20200505,QIS60846.1,IT-TDNTFVSGNCDVVIG,1114,Human,B Cell,Negative,,,ELISA,qualitative binding
204,29666,D064370,20200505,ABE77216.1,IYQTSNFRVVPSGDVVRF,298,Mouse,B Cell,Negative,,,biological activity,neutralization
205,29832,D064370,20200505,ATO98145.1,KAISQIQESLTTTSTAL,889,Human,B Cell,Positive,,,ELISA,qualitative binding
206,30098,D064370,20200505,ABE77216.1,KCYGVSATKL,364,Mouse,B Cell,Negative,,,ELISA,qualitative binding
207,30435,D064370,20200505,QIS60846.1,KEIDRLNEVAKNLNESL,1180,Human,B Cell,Negative,,,ELISA,qualitative binding
208,30987,D064370,20200505,QIS60846.1,KGIYQTSN,309,Human,B Cell,Positive,,,biological activity,antibody binding
209,30988,D064370,20200505,ABE77216.1,KGIYQTSNFRVVPSGDVVRF,296,Human,B Cell,Positive,,,ELISA,qualitative binding
210,31581,D064370,20200505,ABE77216.1,KKISNCVADYSVLYNS-T,342,Human,B Cell,Positive,,,ELISA,qualitative binding
211,31582,D064370,20200505,ABE77216.1,KKISNCVADYSVLYNS-TF,342,Mouse,B Cell,Negative,,,biological activity,neutralization
212,32037,D064370,20200505,AHX37569.1,KLNDLCFSNVYADSFVV,376,Human,B Cell,Positive,,,ELISA,qualitative binding
213,32070,D064370,20200505,ABE77216.1,KLPDDFMGCVLAWNTRN,410,Human,B Cell,Positive,,,ELISA,qualitative binding
214,32138,D064370,20200505,ABE77216.1,KLRPFERDI,446,Mouse,B Cell,Positive,,,ELISA,qualitative binding
215,32508,D064370,20200505,QIQ54048.1,KNHTSPDVDLGD-----ISGIN,1152,Human,B Cell,Positive,,,ELISA,qualitative binding
216,32912,D064370,20200505,AAU93320.1,KPTTFMLKYDENGTITD,257,Human,B Cell,Positive,,,ELISA,qualitative binding
217,33032,D064370,20200505,QIQ54048.1,KQLSSNFGAISSVLNDI,959,Human,B Cell,Negative,,,ELISA,qualitative binding
218,28090,D064370,20200505,ABE77216.1,IPTNFSISI,695,Chimpanzee,MHC Binding,Positive-High,Patr-B*13:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
219,28511,D064370,20200505,QIS60846.1,ISGINASVVNIQKEI,1168,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
220,29008,D064370,20200505,ABE77216.1,ITNFRAILTAFSP----------AQ,227,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
221,29687,D064370,20200505,ABE77216.1,IYST-----GNNVF,620,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
222,30097,D064370,20200505,ABE77216.1,KCYGVSATK,364,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
223,31425,D064370,20200505,ABE77216.1,KISNCVADY,343,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
224,32036,D064370,20200505,ABE77216.1,KLNDLCFSNV,372,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/competitive/fluorescence,qualitative binding
225,32068,D064370,20200505,ABE77216.1,KLPDDFMGC,410,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
226,32069,D064370,20200505,ABE77216.1,KLPDDFMGCV,410,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/competitive/fluorescence,qualitative binding
227,32082,D064370,20200505,ABE77216.1,KLPLGINITNFRAIL,220,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
228,32911,D064370,20200505,ABE77216.1,KPTTFMLKY,257,Human,MHC Binding,Negative,HLA-B*07:02,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
229,32992,D064370,20200505,YP_003858584.1,KQIANQFNK,906,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
230,33038,D064370,20200505,AAU93320.1,KQMY--KTPTLK,767,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
231,33039,D064370,20200505,ABF68955.1,KQMY--KTPTLK----YFGGF,767,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
232,33305,D064370,20200505,ABE77216.1,KSFEIDKGIYQTSNFRVV,290,Mouse,B Cell,Positive,,,biological activity,neutralization
233,33326,D064370,20200505,AAU93320.1,KSGNF--KHLREFVFKNKDGFLYVYKGYQPIDV,174,Guinea pig,B Cell,Negative,,,biological activity,neutralization
234,33358,D064370,20200505,ABE77216.1,KSIVAYTMSLG-ADSSIA,671,Human,B Cell,Positive,,,ELISA,qualitative binding
235,33874,D064370,20200505,YP_003858584.1,KTSVDCNMYICGDSTEC,718,Human,B Cell,Positive,,,ELISA,qualitative binding
236,34217,D064370,20200505,ATO98145.1,KVTLADAGFMKQYGECL,785,Human,B Cell,Negative,,,ELISA,qualitative binding
237,34589,D064370,20200505,ABE77216.1,KYRYLRHGKLRPFERD,438,Rabbit,B Cell,Positive-Low,,,immunohistochemistry,qualitative binding
238,35083,D064370,20200505,ABE77216.1,LCPFGEVF--NATKFPSVY,321,Human,B Cell,Positive,,,ELISA,qualitative binding
239,36167,D064370,20200505,ABE77216.1,LGINITNFRAILTAFSP,223,Human,B Cell,Positive,,,ELISA,qualitative binding
240,36579,D064370,20200505,ABE77216.1,LIKNQCVNFNFNGLTGT,518,Human,B Cell,Positive,,,ELISA,qualitative binding
241,36815,D064370,20200505,ABE77216.1,LKCSVKSFEIDKGIYQT,285,Human,B Cell,Positive,,,ELISA,qualitative binding
242,36856,D064370,20200505,ATO98145.1,LKGACSCGSCCK-FDEDD,1204,Human,B Cell,Positive,,,ELISA,qualitative binding
243,36991,D064370,20200505,ABE77216.1,LKPIFKLPLGINITNFR,215,Human,B Cell,Positive,,,ELISA,qualitative binding
244,37290,D064370,20200505,ATO98193.1,LLFNKVTLADAGFMKQYGECLG---DINA,788,Human,B Cell,Positive,,,ELISA,qualitative binding
245,37316,D064370,20200505,ACO72893.1,LLGCIGSTCA,847,Mouse,B Cell,Negative,,,ELISA,qualitative binding
246,37757,D064370,20200505,ABE77216.1,L----L-RSTS-----QK,664,Human,B Cell,Positive,,,biological activity,antibody binding
247,37758,D064370,20200505,ABE77216.1,L----L-RSTS-----QKSIVAYTMSL,664,Human,B Cell,Positive,,,ELISA,qualitative binding
248,33132,D064370,20200505,ABE77216.1,KRFQPFQQF,542,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
249,33303,D064370,20200505,ABE77216.1,KSFEIDKGIY,290,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
250,33357,D064370,20200505,ABE77216.1,KSIVAYTMSLG-ADSS,671,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
251,33873,D064370,20200505,YP_003858584.1,KTSVDCNMY,718,Chimpanzee,MHC Binding,Negative,Patr-B*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
252,35205,D064370,20200505,QIQ54048.1,LDKYFKNHTSPDVDL,1147,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
253,36050,D064370,20200505,ABE77216.1,LG-ADSSIAY,680,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
254,36075,D064370,20200505,QIS60846.1,LGD-----ISGINASVVNIQ,1165,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
255,36103,D064370,20200505,QIS60846.1,LGFIAGLIAIVMVTI,1217,Human,MHC Binding,Positive-Low,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
256,36458,D064370,20200505,AVP78042.1,LIAIVMVTILLCCMT,1195,Human,MHC Binding,Positive-Low,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
257,36481,D064370,20200505,QIS60846.1,LIDLQELGKY,1196,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
258,36724,D064370,20200505,QIS60846.1,LITGRLQSL,995,Human,MHC Binding,Positive-High,HLA-A2,I,cellular MHC/direct/fluorescence,qualitative binding
259,36990,D064370,20200505,ABE77216.1,LKPIFKLPLGINITN,215,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
260,37289,D064370,20200505,QIQ54048.1,LLFNKVTLA,816,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
261,37544,D064370,20200505,QIS60846.1,LLLQYGSFC,751,Human,MHC Binding,Negative,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
262,37724,D064370,20200505,QIS60846.1,LLQYGSFCT,752,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
263,37845,D064370,20200505,AIA62277.1,LLTDDMIAA,826,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
264,38118,D064370,20200505,YP_003858584.1,LMSFPQAAPHGVVFLHV,1034,Human,B Cell,Positive,,,ELISA,qualitative binding
265,39023,D064370,20200505,AVP78042.1,LQYGSFCTQLNRALSGI,725,Human,B Cell,Positive,,,ELISA,qualitative binding
266,39110,D064370,20200505,ABE77216.1,LRHGKLRPFERDISNVP,442,Human,B Cell,Negative,,,ELISA,qualitative binding
267,40075,D064370,20200505,ABE77216.1,LTPAWRIYST-----GNNVFQ,614,Chicken,B Cell,Positive-Low,,,ELISA,qualitative binding
268,40905,D064370,20200505,ABE77216.1,LYQDVNCTDVSTAIHAD,596,Human,B Cell,Positive,,,ELISA,qualitative binding
269,41177,D064370,20200505,QIQ54048.1,MAYRFNGIGVTQNVLYE,897,Human,B Cell,Positive,,,ELISA,qualitative binding
270,41504,D064370,20200505,ABE77216.1,MFIFLLFLTLTSG--------------SDLD,0,Human,B Cell,Positive,,,ELISA,qualitative binding
271,41984,D064370,20200505,AAU93320.1,MLKYDENGTITDAVDCS,262,Human,B Cell,Positive,,,ELISA,qualitative binding
272,38117,D064370,20200505,YP_003858584.1,LMSFPQAAPHGVVFL,1034,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
273,38353,D064370,20200505,QIQ54048.1,LNTLVKQLSSNFGAI,954,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
274,38429,D064370,20200505,ABE77216.1,LPDDFMGCVL,411,Human,MHC Binding,Negative,HLA-B*54:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
275,38489,D064370,20200505,ABE77216.1,LPFYSNVTGF,59,Human,MHC Binding,Positive-High,HLA-B*35:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
276,38621,D064370,20200505,AIA62277.1,LPPLLTDDMIAAYTA,823,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
277,38831,D064370,20200505,QIQ54048.1,LQDVVNQNAQALNTL,943,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
278,38855,D064370,20200505,QIS60846.1,LQIPFAMQM,893,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
279,38990,D064370,20200505,QIS60846.1,LQSLQTYVTQQLIRA,1000,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
280,39003,D064370,20200505,QIS60846.1,LQTYVTQQLIRAAEI,1003,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
281,39837,D064370,20200505,AIA62277.1,LTDDMIAAY,827,Human,MHC Binding,Negative,HLA-A*02:01,I,purified MHC/direct/fluorescence,qualitative binding
282,40134,D064370,20200505,ABE77216.1,LTQDLFLPFY,53,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
283,40884,D064370,20200505,ABE77216.1,LYNS-TFFSTF,354,Chimpanzee,MHC Binding,Negative,Patr-A*07:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
284,40989,D064370,20200505,AAU93320.1,LYVYKGYQPIDVV----RD,193,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
285,41503,D064370,20200505,ABE77216.1,MFIFLLFLTLTSG--------------SD,0,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
286,41683,D064370,20200505,YP_003858584.1,MIAAYTAAL,854,Human,MHC Binding,Positive-High,HLA-A*02:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
287,41701,D064370,20200505,ABE77216.1,MIFDNAFNC,150,Human,MHC Binding,Negative,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
288,41983,D064370,20200505,AAU93320.1,MLKYDENGTITDAVD,262,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
289,39670,D064370,20200505,ACN89743.1,LSSLLRY-VQAESLSC,357,Mouse,T Cell,Positive,H2-b class II,II,3H-thymidine,proliferation
290,42999,D064370,20200505,AVP78042.1,MVTILLCCMTSCCSCLK,1200,Human,B Cell,Positive,,,ELISA,qualitative binding
291,43145,D064370,20200505,AAU93320.1,NAFNCTFEYISDAFSLD,154,Human,B Cell,Positive,,,ELISA,qualitative binding
292,43264,D064370,20200505,ABE77216.1,NAPATVCGPK-L-----STDLIK,504,Human,B Cell,Positive,,,ELISA,qualitative binding
293,43313,D064370,20200505,ABE77216.1,NASSEVAVLYQDVNCTD,588,Human,B Cell,Positive,,,ELISA,qualitative binding
294,43825,D064370,20200505,ABE77216.1,N---------FELCDNPFFAVSKP-M-G,128,Human,B Cell,Positive,,,ELISA,qualitative binding
295,43834,D064370,20200505,AGC74176.1,NFFSPQIIT-TDNTFVSG,1075,Human,B Cell,Negative,,,ELISA,qualitative binding
296,43893,D064370,20200505,ABE77216.1,NFNGLTGTGVLTP-SSKR,527,Human,B Cell,Positive,,,ELISA,qualitative binding
297,43894,D064370,20200505,ABE77216.1,NFNGLTGTGVLTP-SSKRF,527,Mouse,B Cell,Positive,,,biological activity,neutralization
298,43916,D064370,20200505,ABE77216.1,NFSISI,698,Human,B Cell,Positive,,,biological activity,antibody binding
299,43924,D064370,20200505,AIA62277.1,NFSQILPDPL-----------KPTKRSF,763,Human,B Cell,Negative,,,ELISA,qualitative binding
300,44198,D064370,20200505,ABE77216.1,NIDATS---------------------------TGNYNYKYRYL,426,Human,B Cell,Positive,,,ELISA,qualitative binding
301,44199,D064370,20200505,ABE77216.1,NIDATS---------------------------TGNYNYKYRYLR,426,Mouse,B Cell,Negative,,,biological activity,neutralization
302,45151,D064370,20200505,ABE77216.1,NNKSQSVII--IN--------------------NSTNVV,107,Human,B Cell,Positive,,,ELISA,qualitative binding
303,45506,D064370,20200505,ABE77216.1,NPVIPFKDGIYFAATEK,77,Human,B Cell,Positive,,,ELISA,qualitative binding
304,46240,D064370,20200505,ATO98132.1,NTREVFAQVKQMY--KTPT,759,Human,B Cell,Negative,,,ELISA,qualitative binding
305,46242,D064370,20200505,ABE77216.1,NTRNIDATS---------------------------TGN,423,Human,B Cell,Positive,,,ELISA,qualitative binding
306,46379,D064370,20200505,ABE77216.1,NVFQTQAGCLIGAEHVD,626,Human,B Cell,Positive,,,ELISA,qualitative binding
307,46522,D064370,20200505,AHX37569.1,NVYADSFVVKGDDVRQI,384,Human,B Cell,Positive,,,ELISA,qualitative binding
308,46641,D064370,20200505,ABE77216.1,NYKYRYLRHGKLRPFERDISNVP,436,Mouse,B Cell,Positive-High,,,ELISA,qualitative binding
309,46680,D064370,20200505,ABE77216.1,NYNYKYRYLR,434,Mouse,B Cell,Negative,,,ELISA,qualitative binding
310,46681,D064370,20200505,ABE77216.1,NYNYKYRYLRHGKLRPF,434,Human,B Cell,Positive,,,ELISA,qualitative binding
311,46822,D064370,20200505,AAU93320.1,PAICHE---GKAYFPREGVFVFNGT----------SWFITQRNFFS,1060,Human,B Cell,Positive,,,ELISA,qualitative binding
312,47157,D064370,20200505,AIA62277.1,PDPL-----------KPTKR,769,Mouse,B Cell,Positive,,,ELISA,qualitative binding
313,47341,D064370,20200505,QIQ54048.1,PELDSFKEELDKYFKNH,1138,Human,B Cell,Negative,,,ELISA,qualitative binding
314,47479,D064370,20200505,QIS60846.1,PFAMQMAYRFNGIGVTQ,896,Human,B Cell,Positive,,,ELISA,qualitative binding
315,47565,D064370,20200505,ABE77216.1,PFS-------------------PDGKPCT-PP,458,Human,B Cell,Positive,,,ELISA,qualitative binding
316,47823,D064370,20200505,QDF43815.1,PHGVVFLHVTYVPSQER,1024,Human,B Cell,Positive,,,ELISA,qualitative binding
317,48382,D064370,20200505,AAU93320.1,PL-----------KPTKRSFIEDLLF,790,Human,B Cell,Positive,,,ELISA,qualitative binding
318,48383,D064370,20200505,AAU93320.1,PL-----------KPTKRSFIEDLLFNK,790,Human,B Cell,Positive,,,ELISA,qualitative binding
319,48395,D064370,20200505,ACO72893.1,PLLGCIGSTCAEDGN,846,Mouse,B Cell,Positive,,,ELISA,qualitative binding
320,42873,D064370,20200505,QIS60846.1,MTSCCSCLK,1236,Human,MHC Binding,Positive-Intermediate,HLA-A*11:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
321,43144,D064370,20200505,ABE77216.1,NAFNCTFEY,154,Human,MHC Binding,Negative,HLA-A*31:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
322,43363,D064370,20200505,AVP78042.1,NCDVVIGIINNTVYD,1096,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
323,43863,D064370,20200505,ABE77216.1,NF--KHLREFVF,177,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
324,44170,D064370,20200505,AAR07631.1,NH--------------------TFGNPVIPFKDGI,72,Human,MHC Binding,Positive-Low,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
325,44197,D064370,20200505,ABE77216.1,NIDATS---------------------------TGNY,426,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
326,44472,D064370,20200505,AAU93320.1,NKDGFLYVY,188,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
327,44814,D064370,20200505,QIS60846.1,NLNESLIDL,1191,Human,MHC Binding,Negative,HLA-A*02:01,I,purified MHC/direct/fluorescence,qualitative binding
328,45346,D064370,20200505,ABE77216.1,NPFFAVSKP-M-GT---QTH,134,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
329,45653,D064370,20200505,AAU93320.1,NRALSGIAAEQDRNT,745,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
330,46520,D064370,20200505,QIQ54048.1,NVYADSFVVK,393,Human,MHC Binding,Positive-High,HLA-A*68:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
331,46679,D064370,20200505,ABE77216.1,NYNYKYRYL,434,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
332,47041,D064370,20200505,QIS60846.1,PCSFGGVSVITPGTN,588,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
333,47070,D064370,20200505,ABE77216.1,PDDFMGCVLAWNTRN,412,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
334,47822,D064370,20200505,YP_003858584.1,PHGVVFLHVTYVPSQ,1042,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
335,48554,D064370,20200505,ABE77216.1,P-M-GT---QTHTMIFDNAFNC,142,Human,B Cell,Positive,,,ELISA,qualitative binding
336,49505,D064370,20200505,ABE77216.1,P-SSKRFQPFQQFGRD,539,Rabbit,B Cell,Positive-High,,,immunohistochemistry,qualitative binding
337,49506,D064370,20200505,ABE77216.1,P-SSKRFQPFQQFGRDVSDFT,539,Human,B Cell,Positive,,,ELISA,qualitative binding
338,49507,D064370,20200505,ABE77216.1,P-SSKRFQPFQQFGRDVSDFTDSVRDPKTSE,539,Human,B Cell,Positive,,,ELISA,qualitative binding
339,49557,D064370,20200505,ABE77216.1,PSVYAWERKKISNCVAD,334,Human,B Cell,Positive,,,ELISA,qualitative binding
340,49968,D064370,20200505,AAU93320.1,PVSMAKTSVDCNMYICGDS,709,Human,B Cell,Positive,,,ELISA,qualitative binding
341,50058,D064370,20200505,YP_003858584.1,PWYVWLGFIAGLIAIVM,1198,Human,B Cell,Positive,,,ELISA,qualitative binding
342,50311,D064370,20200505,QIQ54048.1,QALNTLVKQLSSNFGAI,952,Human,B Cell,Positive,,,ELISA,qualitative binding
343,50531,D064370,20200505,ABE77216.1,QDVNCTDVSTAIHADQLTPAWR,598,Human,B Cell,Positive,,,ELISA,qualitative binding
344,50767,D064370,20200505,ABE77216.1,QFGRDVSDFTDSVRDPK,549,Human,B Cell,Positive,,,ELISA,qualitative binding
345,51043,D064370,20200505,ATO98145.1,QIANQFNKAISQIQESL,882,Human,B Cell,Positive,,,ELISA,qualitative binding
346,51097,D064370,20200505,AAU93320.1,QILPDPL-----------KPTKRSFIEDLLFNKVTLA,785,Human,B Cell,Positive,,,biological activity,neutralization
347,51379,D064370,20200505,QIS60846.1,QLIRAAEIRASANLAAT,1010,Human,B Cell,Positive,,,ELISA,qualitative binding
348,51456,D064370,20200505,AAU93320.1,QLNRALSGIAAEQDRNT,743,Human,B Cell,Positive,,,ELISA,qualitative binding
349,51831,D064370,20200505,ABE77216.1,QPFQQFGRDVSDFTDSVRDPKTSEILDISPCSFGGVSVITPGTNASSEVA,545,Human,B Cell,Negative,,,western blot,qualitative binding
350,52020,D064370,20200505,QIS60846.1,QQFGRD,562,Human,B Cell,Positive,,,biological activity,antibody binding
351,52021,D064370,20200505,ABE77216.1,QQFGRDVSDF,548,Mouse,B Cell,Positive,,,ELISA,qualitative binding
352,53116,D064370,20200505,ABF68959.1,RAILTAFSP----------AQDIWGTS,231,Human,B Cell,Positive,,,ELISA,qualitative binding
353,53202,D064370,20200505,QIS60846.1,RASANLAATKMSECVLG,1018,Human,B Cell,Positive,,,ELISA,qualitative binding
354,53435,D064370,20200505,ABE77216.1,RDVSDFTDSVRDPKTSEI,552,Human,B Cell,Positive,,,immuno staining,qualitative binding
355,53766,D064370,20200505,ABE77216.1,RFQPFQQFGRDVSDFTD,543,Human,B Cell,Positive,,,ELISA,qualitative binding
356,48746,D064370,20200505,ABE77216.1,PPALNCYW---------------------------PL,468,Human,MHC Binding,Negative,HLA-B*07:02,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
357,49374,D064370,20200505,ABE77216.1,PSGFNTLKPIFKLPL,209,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
358,49720,D064370,20200505,ABE77216.1,PTNFSISITTEVMPV,696,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
359,50166,D064370,20200505,QIS60846.1,PYRVVVLSF,506,Human,MHC Binding,Negative,HLA-A*29:02,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
360,50641,D064370,20200505,QIS60846.1,QELGKYEQYI,1200,Human,MHC Binding,Negative,HLA-B*18:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
361,50697,D064370,20200505,ATO98145.1,QESLTTTSTA,895,Human,MHC Binding,Negative,HLA-B*18:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
362,51112,D064370,20200505,QIS60846.1,QIPFAMQMAYRFNGI,894,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
363,51251,D064370,20200505,ABE77216.1,QKSIVAYTMSLG-ADS,670,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
364,51659,D064370,20200505,ABF68955.1,QMY--KTPTLK----Y,768,Chimpanzee,MHC Binding,Negative,Patr-B*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
365,51999,D064370,20200505,QIS60846.1,QPYRVVVLSF,505,Human,MHC Binding,Negative,HLA-B*35:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
366,52057,D064370,20200505,QIS60846.1,QQLIRAAEIRASANL,1009,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
367,52236,D064370,20200505,AGC74176.1,QRNFFSPQIIT-TDNT,1073,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
368,52448,D064370,20200505,ABE77216.1,QSVII--IN--------------------NSTNVVIR,111,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
369,52672,D064370,20200505,QIS60846.1,QTYVTQQLIRAAEIR,1004,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
370,52953,D064370,20200505,YP_003858584.1,QYIKWPWYVW,1193,Chimpanzee,MHC Binding,Negative,Patr-A*07:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
371,53307,D064370,20200505,ACN89743.1,RCQIFANI,598,Mouse,MHC Binding,Positive,H2-Kb,I,cellular MHC,qualitative binding
372,53500,D064370,20200505,ABE77216.1,REFVFKNKDG,182,Human,MHC Binding,Negative,HLA-B*18:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
373,53516,D064370,20200505,AKZ19076.1,REGVFVFNG,1058,Human,MHC Binding,Negative,HLA-B*18:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
374,53517,D064370,20200505,AKZ19076.1,REGVFVFNGT,1058,Human,MHC Binding,Negative,HLA-B*18:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
375,53764,D064370,20200505,ABE77216.1,RFQPFQQFGR,543,Human,MHC Binding,Negative,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
376,53789,D064370,20200505,ARB66065.1,RFTNFEPFT,364,Rabbit,B Cell,Positive,,,ELISA,qualitative binding
377,54599,D064370,20200505,QIS60846.1,RLITGRLQSLQTYVTQQ,994,Human,B Cell,Positive,,,ELISA,qualitative binding
378,54989,D064370,20200505,QDF43815.1,RNFTTAPAICHE---GKAYF,1040,Human,B Cell,Positive,,,ELISA,qualitative binding
379,55077,D064370,20200505,ABF68955.1,RNTREVFAQVKQMY--KTPTLK----YFG,757,Rabbit,B Cell,Negative,,,biological activity,neutralization
380,55148,D064370,20200505,ABE77216.1,RPFERDISNV,448,Mouse,B Cell,Negative,,,biological activity,neutralization
381,55149,D064370,20200505,ABE77216.1,RPFERDISNVPFS-------------------PDGK,448,Human,B Cell,Positive,,,ELISA,qualitative binding
382,57196,D064370,20200505,ABE77216.1,SDFTDSVRDPKTS,555,Mouse,B Cell,Positive-Low,,,ELISA,qualitative binding
383,58001,D064370,20200505,ABE77216.1,SGDVVRF-PNITN-LCPFG,309,Human,B Cell,Positive,,,ELISA,qualitative binding
384,58143,D064370,20200505,AVP78042.1,SGNCDVVIGIINNTVYD,1094,Human,B Cell,Positive,,,ELISA,qualitative binding
385,59120,D064370,20200505,ABE77216.1,SLG-ADSSIAYSNNTIAI,679,Human,B Cell,Positive,,,ELISA,qualitative binding
386,59425,D064370,20200505,QIS60846.1,SLQTYVTQQLIRAAEIR,1002,Human,B Cell,Positive,,,ELISA,qualitative binding
387,59944,D064370,20200505,ABE77216.1,SNVPFS-------------------PDGKPCT-PPAL,455,Human,B Cell,Positive,,,ELISA,qualitative binding
388,59985,D064370,20200505,ABF68959.1,SP----------AQDIWGTSAAAYFVG,238,Human,B Cell,Positive,,,ELISA,qualitative binding
389,60014,D064370,20200505,ABE77216.1,S-------------------PDGKPCT-PPALNCYW---------------------------P,460,Human,B Cell,Positive,,,ELISA,qualitative binding
390,60024,D064370,20200505,QIS60846.1,SPDVDLGD-----ISGINAS,1160,Mouse,B Cell,Positive,,,ELISA,qualitative binding
391,54507,D064370,20200505,QIS60846.1,RLDKVEAEV,982,Human,MHC Binding,Positive-High,HLA-A*02:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
392,54680,D064370,20200505,QIS60846.1,RLNEVAKNL,1184,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
393,54725,D064370,20200505,QIS60846.1,RLQSLQTYV,999,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
394,54985,D064370,20200505,AGC74176.1,RNFFSPQIIT-TDNTF,1074,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
395,56252,D064370,20200505,QIS60846.1,RVDFCGKGY,1038,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
396,56691,D064370,20200505,ABE77216.1,SAAAYFVGY,247,Chimpanzee,MHC Binding,Negative,Patr-B*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
397,57592,D064370,20200505,QIS60846.1,SEPVLKGVKL,1260,Human,MHC Binding,Negative,HLA-B*18:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
398,57659,D064370,20200505,ABE77216.1,SEVAVLYQDV,591,Human,MHC Binding,Positive-Intermediate,HLA-B*40:02,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
399,57750,D064370,20200505,QHR63300.2,SFELLNAPATVCGPK,513,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
400,57792,D064370,20200505,QIQ54048.1,SFIEDLLFNK,811,Human,MHC Binding,Negative,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
401,58455,D064370,20200505,ABE77216.1,SIAYSNNTIAIPTNF,685,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
402,58704,D064370,20200505,ABE77216.1,SISITTEVMPVSMAK,700,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
403,58730,D064370,20200505,ABE77216.1,SIVAYTMSL,672,Human,MHC Binding,Positive-High,HLA-A*02:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
404,59161,D064370,20200505,QIS60846.1,SLIDLQELGK,1195,Human,MHC Binding,Positive-Intermediate,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
405,59301,D064370,20200505,ABE77216.1,SL----L-RSTS-----QK,663,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
406,60978,D064370,20200505,ABE77216.1,SSEVAVLYQDVNCTDV,590,Chicken,B Cell,Positive-Intermediate,,,ELISA,qualitative binding
407,61516,D064370,20200505,ABE77216.1,STAIHADQLTPAWRIY,606,Chicken,B Cell,Positive-Intermediate,,,ELISA,qualitative binding
408,61598,D064370,20200505,ABE77216.1,S-TFFSTFKCYGVSATKL,357,Mouse,B Cell,Negative,,,biological activity,neutralization
409,61631,D064370,20200505,ABE77216.1,ST-----GNNVFQTQAGCLIG,622,Chicken,B Cell,Positive-Low,,,ELISA,qualitative binding
410,62403,D064370,20200505,ABE77216.1,SVYAWERKKISNCVADY,335,Mouse,B Cell,Positive,,,ELISA,qualitative binding
411,62872,D064370,20200505,AVP78042.1,TAGWTFGAGAALQIPFA,854,Human,B Cell,Positive,,,ELISA,qualitative binding
412,62908,D064370,20200505,ATO98145.1,TALGKLQDVVNQNAQAL,903,Human,B Cell,Positive,,,ELISA,qualitative binding
413,63120,D064370,20200505,ABE77216.1,TDAVDCSQNPLAELKCSVKSF,272,Rabbit,B Cell,Positive,,,western blot,qualitative binding
414,63266,D064370,20200505,ABE77216.1,TDVSTAIHADQLTPAWRIYST-----G,603,Human,B Cell,Positive,,,ELISA,qualitative binding
415,63309,D064370,20200505,ATO98157.1,TECANLLLQYGSFCTQL,728,Human,B Cell,Positive,,,ELISA,qualitative binding
416,64009,D064370,20200505,ARB66065.1,TGYRFTNFE,361,Rabbit,B Cell,Positive,,,ELISA,qualitative binding
417,64085,D064370,20200505,ABE77216.1,THTMIFDNAFNCTFEYI,147,Human,B Cell,Negative,,,ELISA,qualitative binding
418,64477,D064370,20200505,ABE77216.1,TITDAVDCSQNPLAELK,270,Human,B Cell,Positive,,,ELISA,qualitative binding
419,64563,D064370,20200505,ABE77216.1,TKFPSVYAWERKKISNCVAD,331,Rabbit,B Cell,Negative,,,biological activity,neutralization
420,64888,D064370,20200505,ABF68955.1,TLK----YFGGFNFSQILPDP,774,Human,B Cell,Positive,,,ELISA,qualitative binding
421,60463,D064370,20200505,AIA62277.1,SQILPDPL-----------K,765,Human,MHC Binding,Negative,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
422,60515,D064370,20200505,ABE77216.1,SQNPLAELK,278,Human,MHC Binding,Negative,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
423,61229,D064370,20200505,QIQ54048.1,SSNFGAISSVLNDIL,962,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
424,61515,D064370,20200505,ABE77216.1,STAIHADQLTPAWRI,606,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
425,61554,D064370,20200505,ABE77216.1,STDLIKNQCVNFNFN,515,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
426,61632,D064370,20200505,ABE77216.1,S---------------------------TGNYNYKY,431,Chimpanzee,MHC Binding,Negative,Patr-B*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
427,61633,D064370,20200505,ABE77216.1,S---------------------------TGNYNYKYR,431,Human,MHC Binding,Positive-High,HLA-A*31:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
428,61908,D064370,20200505,ABE77216.1,STS-----QKSIVAY,667,Chimpanzee,MHC Binding,Negative,Patr-B*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
429,62163,D064370,20200505,ABE77216.1,SVII--IN--------------------NSTNVVIRA,112,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
430,62191,D064370,20200505,ABE77216.1,SVKSFEIDK,288,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
431,62221,D064370,20200505,QIS60846.1,SVLNDILSR,974,Human,MHC Binding,Negative,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
432,62402,D064370,20200505,ABE77216.1,SVYAWERKK,335,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
433,62441,D064370,20200505,ATO98145.1,SWFITQRNF,1061,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
434,62442,D064370,20200505,AGC74176.1,SWFITQRNFF,1068,Chimpanzee,MHC Binding,Positive-Intermediate,Patr-A*09:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
435,62793,D064370,20200505,ATO98145.1,TAALVSGTATAGWTF,834,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
436,63133,D064370,20200505,QDF43815.1,TDDMIAAYTAALVSG,833,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
437,63193,D064370,20200505,ABE77216.1,TDLIKNQCVNFNFNG,516,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
438,63580,D064370,20200505,ABE77216.1,TEVMPVSMA,705,Human,MHC Binding,Negative,HLA-B*18:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
439,63581,D064370,20200505,ABE77216.1,TEVMPVSMAKTSVDC,705,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
440,63652,D064370,20200505,ABE77216.1,TFFSTFKCY,358,Human,MHC Binding,Negative,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
441,63664,D064370,20200505,AAR07631.1,TFGNPVIPFK,74,Human,MHC Binding,Positive-High,HLA-A*11:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
442,63951,D064370,20200505,QIS60846.1,TGRLQSLQTYVTQQL,997,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
443,64711,D064370,20200505,ATO98145.1,TLADAGFMK,787,Human,MHC Binding,Negative,HLA-A*31:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
444,65110,D064370,20200505,ABE77216.1,TLTSG--------------SDLDRCTTFD---------DV,8,Human,B Cell,Positive,,,ELISA,qualitative binding
445,65479,D064370,20200505,ABE77216.1,TNVVIRACN---------FELCDNPF,120,Human,B Cell,Positive,,,ELISA,qualitative binding
446,65775,D064370,20200505,ABE77216.1,TP-SSKRFQPFQQFGRDVSDFT,538,Chicken,B Cell,Positive-High,,,ELISA,qualitative binding
447,65832,D064370,20200505,ABE77216.1,TQDLFLPFYSNVTGFH--T,54,Human,B Cell,Positive,,,ELISA,qualitative binding
448,66337,D064370,20200505,ABE77216.1,TSNFRVVPSGDVVRF-PN,301,Human,B Cell,Positive,,,ELISA,qualitative binding
449,66629,D064370,20200505,ARB66065.1,TTGYRFTNF,360,Rabbit,B Cell,Positive,,,ELISA,qualitative binding
450,66630,D064370,20200505,ARB66065.1,TTGYRFTNFEPFTV,360,Mouse,B Cell,Positive,,,ELISA,qualitative binding
451,67220,D064370,20200505,QIS60846.1,TVYDPLQ--PELDSFKEEL,1135,Human,B Cell,Positive,,,ELISA,qualitative binding
452,68971,D064370,20200505,AVP78042.1,VIGIINNTVYDPLQ--PEL,1100,Human,B Cell,Positive,,,ELISA,qualitative binding
453,68972,D064370,20200505,AVP78042.1,VIGIINNTVYDPLQ--PELDSF,1100,Mouse,B Cell,Positive,,,biological activity,neutralization
454,69129,D064370,20200505,ABE77216.1,VITPGTNASSEVAVLY,582,Chicken,B Cell,Positive-Intermediate,,,ELISA,qualitative binding
455,69299,D064370,20200505,ABF68955.1,VKQMY--KTPTLK----YFGGFN,766,Human,B Cell,Positive,,,ELISA,qualitative binding
456,69513,D064370,20200505,QIS60846.1,VLGQSKRVDFCGKGYHL,1032,Human,B Cell,Negative,,,ELISA,qualitative binding
457,69699,D064370,20200505,AIA62277.1,VLPPLLTDDMIAAYTAA,822,Human,B Cell,Positive,,,ELISA,qualitative binding
458,69760,D064370,20200505,QHR63300.2,VLSFELLNAPATVCGPK,511,Human,B Cell,Positive,,,ELISA,qualitative binding
459,69865,D064370,20200505,YP_003858584.1,VLYENQKQIANQFNKAI,900,Human,B Cell,Positive,,,ELISA,qualitative binding
460,65235,D064370,20200505,ABE77216.1,TMNNKSQSV,105,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
461,65831,D064370,20200505,ABE77216.1,TQDLFLPFY,54,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
462,65906,D064370,20200505,QIQ54048.1,TQNVLYENQK,907,Human,MHC Binding,Negative,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
463,66388,D064370,20200505,ABE77216.1,TS-----QKSIVAY,668,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
464,66438,D064370,20200505,ABE77216.1,TSSMRGVYY,33,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
465,66458,D064370,20200505,ABE77216.1,TS---------------------------TGNYNYK,430,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
466,66459,D064370,20200505,ABE77216.1,TS---------------------------TGNYNYKY,430,Chimpanzee,MHC Binding,Negative,Patr-B*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
467,66602,D064370,20200505,ABE77216.1,TTEVMPVSMAKTSVD,704,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
468,66623,D064370,20200505,ABE77216.1,TTGIGYQPY,485,Human,MHC Binding,Negative,HLA-A*23:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
469,66624,D064370,20200505,ABE77216.1,TTGIGYQPYR,485,Human,MHC Binding,Negative,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
470,66849,D064370,20200505,ABE77216.1,T-----TTGIGYQPY,484,Chimpanzee,MHC Binding,Negative,Patr-B*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
471,66875,D064370,20200505,ATO98145.1,TTTSTALGK,899,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
472,67498,D064370,20200505,QDF43815.1,TYVPSQERNF,1033,Chimpanzee,MHC Binding,Negative,Patr-A*07:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
473,68433,D064370,20200505,ATO98145.1,VFAQVKQMY,741,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
474,68434,D064370,20200505,ATO98145.1,VFAQVKQMY--K,741,Human,MHC Binding,Positive-Intermediate,HLA-A*03:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
475,68479,D064370,20200505,ABE77216.1,VFGSTMNNK,101,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
476,68899,D064370,20200505,QIQ54048.1,VIADYNYKL,416,Human,MHC Binding,Positive-High,HLA-A*02:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
477,69298,D064370,20200505,ABF68955.1,VKQMY--KTPTLK----YFGG,766,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
478,69657,D064370,20200505,QIS60846.1,VLNDILSRL,975,Human,MHC Binding,Negative,HLA-A*02:01,I,purified MHC/direct/fluorescence,qualitative binding
479,69759,D064370,20200505,QHR63300.2,VLSFELLNAPATVCG,511,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
480,69864,D064370,20200505,YP_003858584.1,VLYENQKQI,900,Human,MHC Binding,Negative,HLA-A*02:01,I,purified MHC/direct/fluorescence,qualitative binding
481,69882,D064370,20200505,QIQ54048.1,VLYQDVNCT,609,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
482,70032,D064370,20200505,AVP78042.1,VMVTILLCCM,1199,Human,MHC Binding,Negative,HLA-A*02:02,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
483,66460,D064370,20200505,ABE77216.1,TS---------------------------TGNYNYKYRYLRH,430,Mouse,T Cell,Positive,,,bioassay,IFNg release
484,70066,D064370,20200505,QIS60846.1,VNFNFNGL,538,Mouse,T Cell,Negative,H2-b class I,I,ICS,IL-2 release
485,70527,D064370,20200505,ABE77216.1,VQA-------PNYTQHTSSMRGVY,24,Human,B Cell,Positive,,,ELISA,qualitative binding
486,70719,D064370,20200505,QIS60846.1,VRF-PNITN-LCPFGEVF--N,326,Human,B Cell,Positive,,,ELISA,qualitative binding
487,70897,D064370,20200505,ABE77216.1,VSDFTDSV,554,Human,B Cell,Positive,,,biological activity,antibody binding
488,71189,D064370,20200505,ABE77216.1,VSVITPGTNASSEVAVL,580,Human,B Cell,Positive,,,ELISA,qualitative binding
489,71191,D064370,20200505,ABE77216.1,VSVITPGTNASSEVAVLYQDVNCTDVSTAIHADQLTPAWRIYST-----GNNVFQ,580,Human,B Cell,Positive,,,western blot,qualitative binding
490,71589,D064370,20200505,QDF43815.1,VTYVPSQERNFTTAPAI,1032,Human,B Cell,Positive,,,ELISA,qualitative binding
491,72205,D064370,20200505,ABE77216.1,VYYPDEIFRSDTLYLTQD,39,Human,B Cell,Positive,,,ELISA,qualitative binding
492,72519,D064370,20200505,ABE77216.1,WGTSAAAYFVGYLKPTT,244,Human,B Cell,Positive,,,ELISA,qualitative binding
493,73036,D064370,20200505,ABE77216.1,WRIYST-----GNNVFQTQAGC,618,Human,B Cell,Positive,,,ELISA,qualitative binding
494,74173,D064370,20200505,AAU93320.1,YICGDSTECANLLLQYG,722,Human,B Cell,Positive,,,ELISA,qualitative binding
495,74367,D064370,20200505,AAU93320.1,YISDAFSLDVSE-KSGNF,162,Human,B Cell,Positive,,,ELISA,qualitative binding
496,74459,D064370,20200505,ABE77216.1,YKGYQPIDVV----RDLPSGFNTL,196,Rabbit,B Cell,Positive,,,western blot,qualitative binding
497,74895,D064370,20200505,ABE77216.1,YLRHGKLRPFERDISNV,441,Mouse,B Cell,Positive,,,ELISA,qualitative binding
498,74945,D064370,20200505,ABE77216.1,YLTQDL,52,Human,B Cell,Positive,,,biological activity,antibody binding
499,70477,D064370,20200505,ABE77216.1,VPSGDVVRF,307,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
500,70575,D064370,20200505,QIS60846.1,VQIDRLITGR,990,Human,MHC Binding,Positive-High,HLA-A*31:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
501,70701,D064370,20200505,ABE77216.1,VRDPKTSEI,561,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
502,70718,D064370,20200505,QIS60846.1,VRF-PNITN-L,326,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
503,70738,D064370,20200505,ABE77216.1,VRGWVFGSTMNNKSQ,97,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
504,71035,D064370,20200505,ABE77216.1,VSL----L-RSTS-----QK,662,Human,MHC Binding,Negative,HLA-A*68:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
505,71396,D064370,20200505,ATO98145.1,VTLADAGFMK,786,Human,MHC Binding,Negative,HLA-A*33:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
506,71588,D064370,20200505,QDF43815.1,VTYVPSQER,1032,Human,MHC Binding,Positive-High,HLA-A*31:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
507,71663,D064370,20200505,QIS60846.1,VVFLHVTYV,1059,Human,MHC Binding,Positive,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
508,71942,D064370,20200505,YP_003858584.1,VWLGFIAGL,1201,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
509,71981,D064370,20200505,ABE77216.1,VYAWERKKI,336,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
510,71996,D064370,20200505,QIS60846.1,VYDPLQ--PEL,1136,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
511,72409,D064370,20200505,AGC74176.1,WFITQRNFF,1069,Human,MHC Binding,Negative,HLA-A*24:02,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
512,72717,D064370,20200505,QIS60846.1,WLGFIAGLIAIVMVT,1216,Human,MHC Binding,Positive-Intermediate,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
513,72974,D064370,20200505,YP_003858584.1,WPWYVWLGFI,1197,Human,MHC Binding,Negative,HLA-B*07:02,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
514,73192,D064370,20200505,ABE77216.1,WVFGSTMNNK,100,Human,MHC Binding,Negative,HLA-A*31:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
515,73751,D064370,20200505,QIS60846.1,YEQYIKWPWY,1205,Human,MHC Binding,Negative,HLA-B*40:02,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
516,73883,D064370,20200505,AKZ19076.1,YFPREGVFVF,1055,Chimpanzee,MHC Binding,Negative,Patr-A*09:01,I,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
517,74122,D064370,20200505,YP_003858584.1,YHLMSFPQAAPHGVV,1032,Human,MHC Binding,Positive-High,HLA-DRB1*01:01,II,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50)
518,125356,D064370,20200505,ABE77216.1,ADQLTPAWR,611,Mouse,B Cell,Negative,,,antigen inhibition,qualitative binding
519,125415,D064370,20200505,ABE77216.1,FS-------------------PDGKPCT-PPALNCYW,459,Mouse,B Cell,Positive,,,ELISA,qualitative binding
520,78424,D064370,20200505,ACN89743.1,IPRSRQIDLQIG,394,Mouse,B Cell,Positive,,,ELISA,qualitative binding
521,96854,D064370,20200505,ACO72893.1,SA---PSISTE,32,Mouse,B Cell,Positive,,,ELISA,qualitative binding
522,96874,D064370,20200505,ACN89743.1,SIAPDLSL----DFEKLNV,1264,Mouse,B Cell,Positive,,,ELISA,qualitative binding
523,118609,D064370,20200505,AHX37569.1,SNVYADSFVVKGDDVRQIAP,383,Mouse,B Cell,Positive,,,immuno staining,qualitative binding
524,118676,D064370,20200505,ABE77216.1,VYAWERKKISNCVADYSVLYNS-TF,336,Mouse,B Cell,Positive,,,immuno staining,qualitative binding
525,75239,D064370,20200505,ABE77216.1,YNYKYRYLRHGKLRPFERDI,435,Rabbit,B Cell,Negative,,,biological activity,neutralization
526,75528,D064370,20200505,ABE77216.1,YQPIDVV----RDLPSGFNTL,199,Human,B Cell,Positive,,,ELISA,qualitative binding
527,75604,D064370,20200505,ARB66065.1,YRFTNFEPF,363,Mouse,B Cell,Positive,,,ELISA,qualitative binding
528,75843,D064370,20200505,ABE77216.1,YSNVTGFH--T,62,Human,B Cell,Positive,,,ELISA,qualitative binding
529,75920,D064370,20200505,ABE77216.1,YSVLYNS-TFFSTFKCYG,351,Human,B Cell,Positive,,,ELISA,qualitative binding
530,76446,D064370,20200505,AAU93320.1,YVYKGYQPIDVV----RDLPS,194,Human,B Cell,Positive,,,ELISA,qualitative binding
531,117791,D064370,20200505,ABE77216.1,DLPSGFNTL,207,Human,MHC Binding,Positive-Low,HLA-A*02:01,I,cellular MHC/direct/fluorescence,qualitative binding
532,75690,D064370,20200505,ABE77216.1,YRYLRHGKL,439,Human,MHC Binding,Negative,HLA-A*01:01,I,purified MHC/direct/fluorescence,qualitative binding
533,100711,D064370,20200505,ABE77216.1,AGCLIGAEHVDT----SYECDI,632,Human,T Cell,Positive,,,ELISPOT,IFNg release
534,99899,D064370,20200505,AIA62277.1,AQKFNGLTVLPPLLTDDM,814,Human,T Cell,Positive,HLA-DRA*01:01/DRB1*07:01,II,multimer/tetramer,qualitative binding
535,99918,D064370,20200505,AAU93320.1,CTFEYISDAFSLD,158,Human,T Cell,Positive,HLA-DRB1*04:01,II,multimer/tetramer,qualitative binding
536,99926,D064370,20200505,AAU93320.1,DAFSLDVSE-KSGN,165,Human,T Cell,Positive,HLA-DRB1*04:01,II,ELISA,IFNg release
537,78948,D064370,20200505,ACN89743.1,DCK--IEEWL--TAKSVPS,327,Mouse,T Cell,Positive,H2-b class II,II,3H-thymidine,proliferation
538,100778,D064370,20200505,ABE77216.1,DIPIGAGICASYHTVSL----L,648,Human,T Cell,Positive,,,ELISPOT,IFNg release
539,99995,D064370,20200505,ABE77216.1,EIFRSDTLYLTQDLFLPF,44,Human,T Cell,Positive,HLA-DRA*01:01/DRB1*07:01,II,multimer/tetramer,qualitative binding
540,79810,D064370,20200505,QDF43815.1,ERNFTTAPAICHE---GKAYF,1039,Mouse,T Cell,Negative,,,ICS,IFNg release
541,79833,D064370,20200505,AVP78042.1,FVSGNCDVVIGIINNTVY,1092,Mouse,T Cell,Negative,,,ICS,IFNg release
542,100048,D064370,20200505,QIS60846.1,GAALQIPFAMQMAYRF,890,Human,T Cell,Positive,HLA-DRA*01:01/DRB1*07:01,II,multimer/tetramer,qualitative binding
543,100057,D064370,20200505,ATO98193.1,GFMKQYGECLG---DINARDL,799,Human,T Cell,Negative,HLA-DRB1*04:01,II,multimer/tetramer,qualitative binding
544,100230,D064370,20200505,ABE77216.1,KSIVAYTMSLG-ADSSIAY,671,Human,T Cell,Positive,HLA-DRA*01:01/DRB1*07:01,II,multimer/tetramer,qualitative binding
545,100300,D064370,20200505,QIS60846.1,MAYRFNGIGVTQNVLY,901,Human,T Cell,Negative,HLA-DRB1*04:01,II,3H-thymidine,proliferation
546,100316,D064370,20200505,AAU93320.1,NAFNCTFEYISDAFSLDV,154,Human,T Cell,Positive,HLA-DRA*01:01/DRB1*07:01,II,multimer/tetramer,qualitative binding
547,100347,D064370,20200505,ABE77216.1,NPFFAVSKP-M-GT---QTHTMI,134,Human,T Cell,Positive,HLA-DRA*01:01/DRB1*07:01,II,multimer/tetramer,qualitative binding
548,100428,D064370,20200505,QIS60846.1,QLIRAAEIRASANLAATK,1010,Human,T Cell,Negative,HLA-DRB1*04:01,II,multimer/tetramer,qualitative binding
549,100481,D064370,20200505,ABE77216.1,RPFERDISNVPFS,448,Human,T Cell,Positive,HLA-DRB1*04:01,II,ELISA,IFNg release
550,79077,D064370,20200505,ACN89743.1,RY-VQAESLSCNNIDA,362,Mouse,T Cell,Positive,H2-b class II,II,3H-thymidine,proliferation
551,79080,D064370,20200505,ACO72893.1,SGFLQTANYKIDTAA,407,Mouse,T Cell,Negative,,,ELISPOT,IFNg release
552,100537,D064370,20200505,AGC74176.1,SWFITQRNFFSPQII,1068,Human,T Cell,Positive,,,ELISPOT,IFNg release
553,100541,D064370,20200505,ABF68959.1,TAFSP----------AQDIWGTSAAAYF,235,Human,T Cell,Positive,HLA-DRA*01:01/DRB1*07:01,II,multimer/tetramer,qualitative binding
554,100553,D064370,20200505,AAR07631.1,TGFH--TINH--------------------TFGNPVIPFK,66,Human,T Cell,Positive,HLA-DRA*01:01/DRB1*07:01,II,multimer/tetramer,qualitative binding
555,100561,D064370,20200505,ABE77216.1,TLKPIFKLPLGINITNFR,214,Human,T Cell,Positive,HLA-DRA*01:01/DRB1*07:01,II,multimer/tetramer,qualitative binding
556,100567,D064370,20200505,ABF68959.1,TNFRAILTAFSP----------AQDIW,228,Human,T Cell,Negative,HLA-DRB1*04:01,II,multimer/tetramer,qualitative binding
557,100612,D064370,20200505,ABF68955.1,VKQMY--KTPTLK----YFGGFNF,766,Human,T Cell,Negative,HLA-DRB1*04:01,II,multimer/tetramer,qualitative binding
558,100627,D064370,20200505,ABE77216.1,VRGWVFGSTMNNKSQSVI,97,Human,T Cell,Negative,HLA-DRB1*04:01,II,multimer/tetramer,qualitative binding
559,100664,D064370,20200505,ABE77216.1,YLRHGKLRPFERDISNVP,441,Human,T Cell,Positive,HLA-DRB1*04:01,II,multimer/tetramer,qualitative binding
560,100665,D064370,20200505,ABE77216.1,YLTQDLFLPFYSNVTGFH,52,Human,T Cell,Positive,HLA-DRA*01:01/DRB1*07:01,II,multimer/tetramer,qualitative binding
561,75237,D064370,20200505,ABE77216.1,YNYKYRYL,435,Mouse,T Cell,Positive,H2-b class I,I,ICS,IFNg release
562,75238,D064370,20200505,ABE77216.1,YNYKYRYLRHGKLRP,435,Mouse,T Cell,Positive,,,bioassay,IFNg release
563,558386,D064370,20200505,ABE77216.1,ALNCYW---------------------------PLNDY--------------------------GFY-----------------------------------T-----TTGIGYQPYRVVVLSFEL,470,Human,B Cell,Positive,,,ELISA,qualitative binding
564,236157,D064370,20200505,AHY21469.1,CALPDTPSTLTPRS-VRSVPGEMRLAS,735,Rabbit,B Cell,Positive,,,ELISA,qualitative binding
565,236161,D064370,20200505,AHY21469.1,DD-RTEVPQLVN-------------------ANQYS-------PCVSIVPSTVWEDGD------------YYRKQLSPLEGGG-----------------WL,508,Rabbit,B Cell,Positive,,,ELISA,qualitative binding
566,558417,D064370,20200505,QIS60846.1,EIDRLNEVAKNLNESLIDLQELGKYEQY,1181,Human,B Cell,Positive,,,ELISA,qualitative binding
567,148529,D064370,20200505,ABE77216.1,KLRPFERDISNV,446,Chicken,B Cell,Positive,,,western blot,qualitative binding
568,558455,D064370,20200505,QIQ54048.1,LYQDVN,610,Human,B Cell,Positive,,,ELISA,qualitative binding
569,558456,D064370,20200505,QIQ54048.1,LYQDVNC,610,Human,B Cell,Positive,,,ELISA,qualitative binding
570,558457,D064370,20200505,QIQ54048.1,LYQDVNCT,610,Human,B Cell,Positive,,,ELISA,qualitative binding
571,558458,D064370,20200505,ABE77216.1,LYQDVNCTDVSTAIHADQLTPAWRIYST-----G,596,Human,B Cell,Positive,,,ELISA,qualitative binding
572,149456,D064370,20200505,ATO98193.1,RSFIEDLLFNKVTLADAGFMKQYGECLG---DINARDLICAQKFNGLTVLP,782,Mouse,B Cell,Positive,,,biological activity,neutralization
573,558510,D064370,20200505,ABE77216.1,TDVSTAIHADQLTPAWRIYST-----G,603,Human,B Cell,Positive,,,ELISA,qualitative binding
574,125586,D064370,20200505,ABE77216.1,TTGIGYQ,485,Mouse,B Cell,Negative,,,surface plasmon resonance (SPR),dissociation constant KD
575,422251,D064370,20200505,Q02385.1,CSLWNGPHL,509,Mouse,MHC Binding,Positive,H2-Db,I,cellular MHC,qualitative binding
576,231893,D064370,20200505,YP_003858584.1,FPQAAPHGV,1037,Human,MHC Binding,Positive-Low,HLA-B*07:02,I,purified MHC/direct/radioactivity,half life
577,616629,D064370,20200505,AHY21469.1,FYAPEPIT-SL,1190,Mouse,MHC Binding,Positive,H2-Kd,I,x-ray crystallography,3D structure
578,620933,D064370,20200505,AHY21469.1,KYYSIIPHSI,290,Mouse,MHC Binding,Positive,H2-Kd,I,purified MHC/direct/fluorescence,50% dissociation temperature
579,625112,D064370,20200505,AHY21469.1,SFYAPEPIT-SL,1189,Mouse,MHC Binding,Positive,H2-Kd,I,x-ray crystallography,3D structure
580,628707,D064370,20200505,AHY21469.1,YYSIIPHSI,291,Mouse,MHC Binding,Positive,H2-Kd,I,purified MHC/direct/fluorescence,50% dissociation temperature
581,616139,D064370,20200505,AGY29650.2,FAQSIFYRL,962,Mouse,T Cell,Positive-Intermediate,H2-Kd,I,ELISPOT,IFNg release
582,616628,D064370,20200505,AHY21469.1,FYAPEPIT-S,1190,Mouse,T Cell,Positive-Low,H2-Kd,I,ELISPOT,IFNg release
583,616635,D064370,20200505,AGY29650.2,FYRLNGVGI,967,Mouse,T Cell,Positive-Low,H2-Kd,I,ELISPOT,IFNg release
584,616636,D064370,20200505,AGY29650.2,FYRLNGVGIT,967,Mouse,T Cell,Positive,H2-Kd,I,ELISPOT,IFNg release
585,146966,D064370,20200505,ACN89742.1,GGNSIIGFWHTD-IK-S,170,Mouse,T Cell,Negative,H2-b class I,I,ICS,IFNg release
586,532052,D064370,20200505,AGC74176.1,GT----------SWFITQRNFFSPQ,1066,Human,T Cell,Positive,HLA class II,II,ELISPOT,IFNg release
587,187223,D064370,20200505,ACZ71991.1,HNYKYRYL,435,Mouse,T Cell,Negative,H2-b class I,I,ICS,IL-2 release
588,147025,D064370,20200505,AID16661.1,IDDINFSPLLGCLGS,882,Mouse,T Cell,Negative,H2-b class I,I,ICS,IFNg release
589,620932,D064370,20200505,AHY21469.1,KYYSIIPHS,290,Mouse,T Cell,Positive-Low,H2-Kd,I,ELISPOT,IFNg release
590,147114,D064370,20200505,Q5MQD0.1,LSDVGFVEAYNNCTG,916,Mouse,T Cell,Negative,H2-b class I,I,ICS,IFNg release
591,147122,D064370,20200505,ACN89742.1,LTTFEPFTVSIVNDS,765,Mouse,T Cell,Negative,H2-b class I,I,ICS,IFNg release
592,147241,D064370,20200505,AID16661.1,RCHIFSNLL,588,Mouse,T Cell,Negative,H2-Kb,I,ICS,IFNg release
593,625110,D064370,20200505,AGY29650.2,SFYAPEPI,1180,Mouse,T Cell,Positive-Low,H2-Kd,I,ELISPOT,IFNg release
594,625111,D064370,20200505,AGY29650.2,SFYAPEPIT,1180,Mouse,T Cell,Positive-Low,H2-Kd,I,ELISPOT,IFNg release
595,147293,D064370,20200505,AID16661.1,SLLRF-VQAESLSCSN,359,Mouse,T Cell,Negative,H2-b class I,I,ICS,IFNg release
596,533900,D064370,20200505,ABE77216.1,SSKRFQPFQQFGRDV,540,Human,T Cell,Positive,HLA class II,II,ELISPOT,IFNg release
597,147348,D064370,20200505,ACN89742.1,TTY------DLRCL,531,Mouse,T Cell,Negative,H2-Kb,I,ICS,IFNg release
598,147369,D064370,20200505,AID16661.1,VGLVYRRV,315,Mouse,T Cell,Negative,H2-Kb,I,ICS,IFNg release
599,181163,D064370,20200505,ABE77216.1,YGVSATKL,366,Mouse,T Cell,Positive,H2-Kd,I,ELISPOT,IFNg release
600,628706,D064370,20200505,AHY21469.1,YYSIIPHS,291,Mouse,T Cell,Positive-Low,H2-Kd,I,ELISPOT,IFNg release
601,917806,D064370,20200505,K9N5Q8.1,TKPLKYSYINKCSRFLSDD-RTEVPQ,491,Mouse,B Cell,Positive,,,ELISA,dissociation constant KD
602,917807,D064370,20200505,AHY21469.1,TKPLKYSYINKCSRLLSDD-RTEVPQ,491,Mouse,B Cell,Positive,,,ELISA,dissociation constant KD
603,871495,D064370,20200505,AHY21469.1,VYDT---IKYYSIIPHSI,285,Mouse,T Cell,Negative,H2-d class I,I,ICS,IL-2 release
